Venus Remedies Limited (NSE:VENUSREM)
India · Delayed Price · Currency is INR 1,665.80
+22.10 (1.34%)
Sep 24, 2026, 11:53 AM IST
Venus Remedies Market Cap
Venus Remedies has a market cap or net worth of 22 billion as of September 23, 2026. Its market cap has increased by 258.24% in one year.
Market Cap
22.00B
Enterprise Value
21.09B
Revenue
8.11B
Ranking
n/a
PE Ratio
18.94
Stock Price
1,665.80
ChartMarket Cap Chart
Since October 19, 2004, Venus Remedies's market cap has increased from 242.83M to 22.00B, an increase of 8,961.13%. That is a compound annual growth rate of 22.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 22.00B | 114.62% |
| Dec 31, 2025 | 10.25B | 139.58% |
| Dec 31, 2024 | 4.28B | -21.14% |
| Dec 29, 2023 | 5.43B | 124.10% |
| Dec 30, 2022 | 2.42B | -55.77% |
| Dec 31, 2021 | 5.48B | 194.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orchid Pharma | 54.87B |
| RPG Life Sciences | 45.65B |
| Solara Active Pharma Sciences | 36.34B |
| Ind-Swift Laboratories | 32.99B |
| Sakar Healthcare | 25.78B |
| Indoco Remedies | 23.78B |
| Windlas Biotech | 23.31B |
| Beta Drugs | 21.03B |